fashion -WSS

fashion

author：explore 2025-10-02 01:07:06 - browse：7926

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Newly revealed memo details efforts to keep Trump in power following election loss

focus

WSS

Some of the ways extreme heat will change life as we know it

Cybersecurity threat forces Lurie Children's to take systems offline

Do digital therapeutics have a future in medicine?

Vertigo drug brings hope for rare neuron disorder, Niemann

Even great ERs can’t make up for American health disparities

Novo acquires Inversago for up to $1 billion

leisure time

fashion

explore

At least 13 dead in Texas as scorching temps continue

New Ultima Genomics DNA sequencer can read genome for $100

Novavax promises a turnaround & Lilly roils the obesity market

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Dobbs anniversary: the lost opportunity of abortion as health care

Large hospital system sues Multiplan for low

Medicare proposal to cover medical devices draws a mixed reaction

The lessons of Aduhelm, an Alzheimer's drug that was not to be

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Target recalls 2.2 million additional candles due to laceration, burn hazards

entertainment

O'Shea Sibley was killed after expressing queer joy by voguing, activists say

CDC overhauls leadership of center that led response to Covid

Novo Nordisk to expand supply of Wegovy for U.S. patients

Cybersecurity threat forces Lurie Children's to take systems offline

A $475,000 price tag for a new cancer drug: crazy or meh?

SAMSHA loosens regulations on methadone treatment centers

focus

focus

focus

entertainment